Huntsman Cancer Institute at the University of Utah

November 10, 2021

Findings from biomarker tests for patients with chronic lymphocytic leukemia can help appropriately tailor therapy plans as well as identify patients eligible for clinical trials.

October 15, 2021

“Previously, this mutation has been undruggable, but this is now changing.”

October 04, 2021

Kristin Barber, FNP-BC, AOCNP, discusses ongoing phase 1 trials aimed at targeting mutations along the MAP kinase pathway.